Strong Buy on DM1 & DMD clinical progress, BLA timeline, and strong cash runway through 2028. Click for this DYN update.

InSphero AG, a global leader in advanced 3D in vitro models and services for drug safety and efficacy testing, today announced the acquisition of PhenoVista Biosciences, Inc., a premier provider of ...

As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, select biotech companies ...

The University of Cebu Medical Center (UCMed) introduced its new Hyperbaric Oxygen Therapy (HBOT), a noninvasive and ...

The recent approval of Regeneron’s Otarmeni underscores the maturation of gene therapies across a range of diseases. Here, ...

Hematology Market OverviewThe global hematology market is projected to grow at a CAGR of approximately 3–5% through 2027.

Genethon, the French pioneer in the discovery and development of gene therapies for rare diseases, and Ampersand Biomedicines, a Flagship Pioneering multi-product platform company developing smarter ...

I recently had the good fortune of going for a walk on a section of the Okanagan Rail Trail near Dilworth Mountain in Kelowna ...

A collage of a woman wearing red light therapy devices. I’ve reached a delightful era of my life wherein I’m regularly ...

Dyno Therapeutics launches two new AAV Capsids, AI platform for rare disease therapeutic development: Watertown, Massachusetts Saturday, May 16, 2026, 13:00 Hrs [IST] Dyno Therape ...

Taking care of one’s health today goes beyond treating illness. It is  increasingly about helping the body to recover, ...

Mercedes-AMG has unveiled the all-electric GT 4-Door Coupé, featuring revolutionary axial-flux motors, up to 1,169bhp, Formula 1-inspired battery technology and advanced aerodynamics to redefine ...